ARTICLE | Clinical News
HYAL-CT1101: Began Phase II trial in Canada
September 20, 1993 7:00 AM UTC
Hyal Pharmaceutical Corp. (HYALF) Product: HYAL-CT1101, hyaluronic acid and diclofenac Indication: Treat actinic keratosis Status: Began Phase II trial in Canada ...